RobertTylerHillmanMD

Gynecologic Oncology

Clinical Fellow

Dr. Hillman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Diego) Medical CenterResidency, Obstetrics and Gynecology, 2012 - 2016
Stanford University School of MedicineClass of 2012
Stanford University School of MedicinePh.D., Genetics, 2004 - 2010
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology

Howard Hughes Medical Institute Medical Research Fellow Howard Hughes Medical Institute, 2005-2006

PubMed

Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2-C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors.
Thomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, Allison Brodsky, Alejandra Flores Legarreta
Cancer Research. 2024-12-09
promoter mutations and survival outcomes in adult-type granulosa cell tumors.
Allison L Brodsky, Alejandra Flores Legarreta, Bryan M Fellman, Deanna Glassman, Jeffrey How
International Journal of Gynecological Cancer. 2024-11-21
Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement.
M Sol Basabe, Tina S Suki, Mark F Munsell, Maria D Iniesta, Juan E Garcia Lopez
International Journal of Gynecological Cancer. 2024-02-05

Journal Articles

KMT2D/MLL2 Inactivation Is Associated with Recurrence in Adult-Type Granulosa Cell Tumors of the Ovary
R Tyler Hillman, Karen H Lu, David M Gershenson, Nature